Ipca Laboratories Limited - Company Profile

Q: Who are the current directors of Ipca Laboratories Limited?

The current directors of Ipca Laboratories Limited are Vivek Keshav Shiralkar, Pranay Premchand Godha, Harish Pandurang Kamath, Ajit Kumar Jain, Prashant Premchand Godha, Narendra Mairpady, Premchand Gigalal Godha, Swati Arvind Patankar, Kamal Kishore Seth.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1949.

1949 Mumbai, Maharashtra, India Active

Last Updated: January 04, 2026

Access Report

About Ipca Laboratories Limited

Ipca Laboratories Limited, a active public limited company, was established on 19 October 1949 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239MH1949PLC007837. Registered under ROC Roc Mumbai. it is listed on BSE: 524494 and NSE: IPCALAB. It has an authorized capital of ₹57.60 Cr and a paid-up capital of ₹25.37 Cr.

Formerly known as The Indian Pharmaceutical Combine Association Ltd. It upholds a compliant status. In 2024, it reported revenue of ₹6,277.75 Cr and a net worth of ₹6,348.71 Cr. Employing 17,422 professional, Its leadership includes Vivek Keshav Shiralkar (Director), Pranay Premchand Godha (Managing Director), Prashant Premchand Godha (Director). Past directors included Vishnu Atmaram Gore, Vivek Keshav Shiralkar, Ramappa Siddharamappa Hugar. It holds ₹2,708.14 Cr open charges and ₹2,002.16 Cr settled loans. Its latest AGM occurred on 11 August 2025, with the balance sheet filed on 31 March 2025. It is based at 48 Kandivli Industrialestate Kandivali (W), Mumbai, Maharashtra, 400067.

Company Details

CIN/LLPIN
L24239MH1949PLC007837
Registration Number
007837
Incorporation Date
19 October 1949
Authorized Capital
₹57.60 Cr
Paid-Up Capital
₹25.37 Cr
ROC Code
Roc Mumbai
Listing Status
Listed (BSE: 524494, NSE: IPCALAB)
Company Status
Active

Key Metrics

Authorised Capital ₹ 57.60 Cr as on 04-01-2026
Paid Up Capital ₹ 25.37 Cr as on 04-01-2026
Company Age 76 Year, 4 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 2,708.14 Cr as on 04-01-2026
Satisfied Charges ₹ 2,002.16 Cr as on 04-01-2026
Revenue Growth **** 5.94% (FY 2024)
Profit Growth **** 4.89% (FY 2024)
Ebitda **** 32.85% (FY 2024)
Net Worth 8.02% (FY 2024)
Total Assets **** 2.51% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Ipca Laboratories Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Ipca Laboratories Limited?

Current Directors

Name	Designation	Appointment Date	Status
Vivek Keshav Shiralkar	Director	29 May 2024	Current
Pranay Premchand Godha	Managing Director	30 Jul 2009	Current
Prashant Premchand Godha	Director	28 Jul 2011	Current
Harish Pandurang Kamath	Nodal Officer	28 Aug 2019	Current
Narendra Mairpady	Director	20 Oct 2022	Current
Premchand Gigalal Godha	Whole-Time Director	31 Jan 2012	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	02 Dec 2009	Past
Pramod Abcsdd	Additional Director	12 Aug 2024	Past
Pramod Abcsdd	Director	30 Jan 2013	Past
Pramod Abcsdd	Additional Director	11 Nov 2008	Past
Pramod Abcsdd	Director	01 Apr 2019	Past
Pramod Abcsdd	Director	20 Sep 2019	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ipca Laboratories.

Ipca Laboratories Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 5.94% increase. The company also saw a slight improvement in profitability, with a 4.89% increase in profit. The company's net worth moved up by a moderate rise of 8.02%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

5.94%

*******

Revenue from Operations

*******

6.05%

*******

Total Assets

*******

2.51%

*******

Profit or Loss

*******

4.89%

*******

Net Worth

*******

8.02%

*******

EBITDA

*******

32.85%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ipca Laboratories?

In 2024, Ipca Laboratories had a promoter holding of 46.30% and a public holding of 53.70%. The company had 3 Subsidiaries, 2 Joint Ventures and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹27,081,433,619.00

Satisfied Charges

₹20,021,565,491.00

Charges Breakdown by Lending Institutions

Idbi Trusteeship Services Limited : 1510.00 Cr
Hdfc Bank Limited : 691.22 Cr
Citi Bank N.A. : 166.60 Cr
The Hongkong And Shanghai Banking Corporation Limited : 123.71 Cr
Jp Morgan Chase Bank, N.A. : 114.21 Cr
Others : 102.41 Cr

Latest Charge Details

Date	Lender	Amount	Status
24 Jan 2025	Citi Bank N.A.	₹166.60 Cr	Open
29 Aug 2023	Hdfc Bank Limited	₹300.00 Cr	Open
08 Aug 2023	The Hongkong And Shanghai Banking Corporation Limited	₹123.71 Cr	Open
07 Oct 2022	Hdfc Bank Limited	₹391.22 Cr	Open
02 Aug 2022	Jp Morgan Chase Bank, N.A.	₹114.21 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Ipca Laboratories?

Ipca Laboratories has a workforce of 17422 employees as of Feb 28, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Ipca Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipca Laboratories's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ipca Laboratories

Recent Activity within the Organization

Annual General Meeting

The activity Ipca Laboratories Limited last Annual general meeting of members was held on 11 Aug 2025 as per latest MCA records. was completed.
11 Aug 2025
Balance Sheet

The activity Ipca Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
31 Mar 2025
Charges

Progress on A charge with Citi Bank N.A. amounted to Rs. 166.60 Cr with Charge ID 101041701 was registered on 24 Jan 2025. was documented.
24 Jan 2025
Director Appointment

The activity Vivek Keshav Shiralkar was appointed as a Director was appointed as a Director on 29 May 2024 & has been associated with this company since 1 year 9 months . was completed.
29 May 2024
Director Appointment

Swati Arvind Patankar was appointed as a Director was appointed as a Director on 14 Feb 2024 & has been associated with this company since 2 years 20 days . was recorded as a recent event.
14 Feb 2024
Charges

A charge with Hdfc Bank Limited amounted to Rs. 300.00 Cr with Charge ID 100775715 was registered on 29 Aug 2023. was recorded as a recent event.
29 Aug 2023

Explore recent activity and updates - View Recent Activity